Investors
Careers
Contact Us
About Us
Our Products
Our Pipeline
Our Technology
Investor Relations
Press Releases
Stock Quote and Chart
Fundamentals
Events Calendar
SEC Filings
Corporate Governance
Investor Kit
Analysts
Email Alerts
Proxy Materials
RSS Feeds
Printer Friendly Version
Press Releases
2010 |
2009
|
2008
|
2007
|
2006
Keyword Search
Date
Title
02/02/10
Depomed to Present at the 12th Annual BIO CEO & Investor Conference
02/01/10
Depomed Announces Allowance of U.S. Patent Covering Gastric Retentive Gabapentin Dosage Forms
01/21/10
Depomed Announces Receipt of $500,000 Milestone Payment from Covidien for the Development of a Second Formulation
01/19/10
Depomed Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes